Mr. Haifeng Cao joined Reistone in 2018 as the VP, head of regulatory affairs, PV and external affairs. Mr. Haifeng Cao has 19 years experiences in regulatory affairs with several top multinational pharma in China.
Before joining Reistone, Haifeng worked in GSK and BI China as the head of regulatory affairs, where he made great contributions to build and lead the China regulatory affairs teams, develop fit-in purpose China development strategy for global innovative product and governed their execution. More than 20 new product approvals were obtained in Oncology, NS, Infectious, Derm, Diabetes, CV, Immunology, Respiratory and Vaccines etc. with Mr. Haifeng Cao’s strong leadership.
Haifeng holds a BS in Chemistry from JiLin University, a Master in Chemistry from Chinese Academy of Sciences and an MBA from Renmin University.